Positive influence of tetracycline on human fetal kidney in serum-free organ culture.
Human fetal kidney explants can be maintained during 5 days in Leibovitz's L15, a basic serum-free medium. Because culture conditions are minimal for growth and differentiation, DNA synthesis drastically decreases during the first 48 h, but stabilizes thereafter. The addition of insulin plus transferrin significantly restores this important cellular function in kidneys of fetuses younger than 16 wk. However, renal explants from older fetuses are more difficult to culture: they respond less to growth factors and are more prone to necrosis. The objective of this study was to verify the influence of tetracycline, an antibiotic with anti-collagenase potential, on cultured kidney explants aged 17 to 20 wk. The addition of 20 micrograms/ml tetracycline did not influence DNA synthesis nor the effectiveness of insulin plus transferrin on cell proliferation. Nor did it change the activities of alkaline phosphatase and gamma-glutamyltransferase, two enzymic markers of brush border differentiation. After 5 days in L15 alone, explants often showed necrosis and an important reduction in both weight and volume. Insulin plus transferrin significantly restored these parameters to control values observed at Day 0, but evidence of necrosis was still present. Tetracycline alone markedly reduced explant necrosis resulting in a significant increase in weight and volume. The effectiveness of insulin plus transferrin on explant morphometry was not improved when tetracycline was added as third factor. These results indicate that insulin plus transferrin restores explant mass through cell proliferation, whereas tetracycline does so possibly through a reduction in extracellular matrix degradation. The two effects are not additive in cultured mid-term fetal kidneys.
Brière
N
N
Département d'anatomie et de biologie cellulaire, Faculté de médecine, Université de Sherbrooke, Québec, Canada.
Chailler
P
P
D000469:Alkaline Phosphatase / Q000032:analysis / Q000378:metabolism; D002478:Cells, Cultured; D016895:Culture Media, Serum-Free / Q000494:pharmacology*; D004247:DNA / Q000378:metabolism; D005333:Fetus / Q000166:cytology* / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D007668:Kidney / Q000166:cytology* / Q000196:embryology* / Q000378:metabolism; D009924:Organ Culture Techniques; D013752:Tetracycline / Q000494:pharmacology*; D014168:Transferrin / Q000494:pharmacology; D005723:gamma-Glutamyltransferase / Q000032:analysis / Q000378:metabolism
D016895:Culture Media, Serum-Free; D007328:Insulin; D014168:Transferrin; D004247:DNA; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase; D013752:Tetracycline